Menu
Back to User profile » Dr Xuanxuan Dai
Papers published by Dr Xuanxuan Dai:
L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]
Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C
Cancer Management and Research 2019, 11:10683-10684
Published Date: 23 December 2019
Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway
Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang XY, Zhu J, Zhao C
Cancer Management and Research 2019, 11:1167-1176
Published Date: 1 February 2019
A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X
Cancer Management and Research 2018, 10:3069-3082
Published Date: 29 August 2018
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C
Cancer Management and Research 2018, 10:565-581
Published Date: 23 March 2018
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
OncoTargets and Therapy 2017, 10:1767-1776
Published Date: 23 March 2017